Life science

Found 64 executive insights

Life science

Display results per page

2018 outlook for drugs and medical devices in China: regulatory reform fueled by innovation

This article explores possible further regulatory reform in China in 2018 regarding the regulatory approval system for drugs and medical devices.

Law Firm: DLA Piper | Published: 19 January 2018 | Practice Area: Health Care

Justice Department kills the weed buzz, leaves Treasury guidance in a haze

Recent DOJ action on marijuana will be broadly felt, bringing again to the forefront the tension between federal drug law and state marijuana law. This briefing takes a closer look.

Law Firm: Reed Smith | Published: 09 January 2018 | Practice Area: Social Welfare

Food and Beverage News and Trends: December 2017

This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal and regulatory landscape.

Law Firm: DLA Piper | Published: 20 December 2017 | Practice Area: Betting Gaming and Leisure

Rating: 2 people found this useful

Food and Beverage News and Trends

This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal and regulatory landscape.

Law Firm: DLA Piper | Published: 08 December 2017 | Practice Area: Consumer

Product liability implications in the digital health industry

In this alert, DLA Piper lawyers review key product liability considerations for companies and investors in the healthcare and life sciences sectors that are contemplating entry into the digital health frontier.

Law Firm: DLA Piper | Published: 04 December 2017 | Practice Area: Health and Safety

Rating: 5 people found this useful

Mind the Actavis v Eli Lilly gap please!

Is there a gap between the interpretation of a patent claim for validity purposes and its reach for infringement purposes? If so, what are the practical implications?

Law Firm: Gowling WLG | Published: 28 November 2017 | Practice Area: Litigation

Healthcare restructurings: four key issues to consider before a chapter 11 filing

Providers in financial distress should be mindful of the ways in which healthcare restructurings are different. This briefing outlines the key differences.

Law Firm: DLA Piper | Published: 10 November 2017 | Practice Area: Health Care

Rating: 2 people found this useful

FDA withdraws draft guidance for Industry #230

The U.S. Food & Drug Administration is withdrawing the draft guidance for Industry #230, “Compounding Animal Drugs from Bulk Drug Substances.” This briefing explains why that's good news for industry stakeholders.

Law Firm: Reed Smith | Published: 09 November 2017 | Practice Area: Administrative and Public Law

Food and Beverage News and Trends: November 2017

This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal and regulatory landscape.

Law Firm: DLA Piper | Published: 08 November 2017 | Practice Area: Administrative and Public Law

Close encounters: quantifying the power of collaborative innovation

Collaborative innovation, in the form of partnerships with dynamic SMEs, has emerged as a key strategy for corporate innovation. This study aims to quantify collaborative deals between UK SMEs and domestic and international corporates and reveal how firms are choosing to collaborate.

Law Firm: Womble Bond Dickinson | Published: 01 November 2017 | Practice Area: Joint Ventures

Rating: 3 people found this useful

Find Executive Insights

Categories related to Life science

As a member of Law.com | Executive Insights you will receive free access to our library of insights from world’s leading law firms and companies. Content is easy to find and constantly being updated. You can also discover what insights your peers in other companies are looking at.

  • Stay informed
  • Rate content
  • Save documents
  • Receive email alerts

Featured Law Firms

Lathamlogo Dla
Grant thornton Bowmans0703-150x94
Shoo new logo Wbd-logo-rgb-150dpi0211-150x94